相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer
Lihi Bar-Lev Schleider et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Medical Oncologists' Beliefs, Practices, and Knowledge Regarding Marijuana Used Therapeutically: A Nationally Representative Survey Study
Ilana M. Braun et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain
Aron H. Lichtman et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2018)
Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population
Ashley C. Bradford et al.
JAMA INTERNAL MEDICINE (2018)
Association of Marijuana Use With Psychosocial and Quality of Life Outcomes Among Patients With Head and Neck Cancer
Han Zhang et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2018)
Labeling Accuracy of Cannabidiol Extracts Sold Online
Marcel O. Bonn-Miller et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Chronic pain patients' perspectives of medical cannabis
Brian J. Piper et al.
PAIN (2017)
Cannabidiol: State of the art and new challenges for therapeutic applications
Simona Pisanti et al.
PHARMACOLOGY & THERAPEUTICS (2017)
A selective review of medical cannabis in cancer pain management
Alexia Blake et al.
ANNALS OF PALLIATIVE MEDICINE (2017)
Cannabis Use Among Patients at a Comprehensive Cancer Center in a State With Legalized Medicinal and Recreational Use
Steven A. Pergam et al.
CANCER (2017)
Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies
Marie T. Fallon et al.
BRITISH JOURNAL OF PAIN (2017)
A two-part safety and exploratory efficacy randomized double-blind, placebo-controlled study of a 1:1 ratio of the cannabinoids cannabidiol and delta-9-tetrahydrocannabinol (CBD:THC) plus dose-intense temozolomide in patients with recurrent glioblastoma multiforme (GBM).
Chris Twelves et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial
Mathieu Cote et al.
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2016)
A user's guide to cannabinoid therapies in oncology
V. Maida et al.
CURRENT ONCOLOGY (2016)
Medical Marijuana Use in Oncology A Review
Gianna Wilkie et al.
JAMA ONCOLOGY (2016)
Cannabis in Cancer Care
D. I. Abrams et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Medical Marijuana for Cancer
Joan L. Kramer
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced Neuropathic Pain
Mary E. Lynch et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2014)
Cannabinoids as therapeutic agents in cancer: current status and future implications
Bandana Chakravarti et al.
ONCOTARGET (2014)
Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010
Marcus A. Bachhuber et al.
JAMA INTERNAL MEDICINE (2014)
The Medical Necessity for Medicinal Cannabis: Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care
Gil Bar-Sela et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics
Jeremy R. Johnson et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2013)
Cannabis Extract Treatment for Terminal Acute Lymphoblastic Leukemia with a Philadelphia Chromosome Mutation
Yadvinder Singh et al.
CASE REPORTS IN ONCOLOGY (2013)
Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial
Russell K. Portenoy et al.
JOURNAL OF PAIN (2012)
Cannabinoids in the Treatment of Chemotherapy-Induced Nausea and Vomiting
Barbara Todaro
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial
T. D. Brisbois et al.
ANNALS OF ONCOLOGY (2011)
Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas-possible role of Cannabis inhalation
Mansoor Foroughi et al.
CHILDS NERVOUS SYSTEM (2011)
Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting
Marta Duran et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain
Jeremy R. Johnson et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2010)
Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting
Eyal Meiri et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Human cannabinoid pharmacokinetics
Marilyn A. Huestis
CHEMISTRY & BIODIVERSITY (2007)
Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: A multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the cannabis-in-cachexia-study-group
Florian Strasser et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A pilot clinical study of Δ9- tetrahydrocannabinol in patients with recurrent glioblastoma multiforme
M. Guzman et al.
BRITISH JOURNAL OF CANCER (2006)
Dronabinol for supportive therapy in patients with malignant melanoma and liver metastases
M. Zutt et al.
HAUTARZT (2006)
分享论文
